Innova Captab Limited (INNOVACAP.NS)
INR 875.7
(5.21%)
INR 875.7
(5.21%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.33 Billion INR | -44.37% |
| 2022 | 4.19 Billion INR | 110.78% |
| 2021 | 1.99 Billion INR | 388.96% |
| 2020 | 407.02 Million INR | 0.0% |
| 2019 | - INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 4.56 Billion INR | 11.07% |
| 2023 FY | 2.33 Billion INR | -44.37% |
| 2023 Q4 | 2.33 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | 4.11 Billion INR | -1.94% |
| 2022 Q4 | 4.19 Billion INR | 0.0% |
| 2022 FY | 4.19 Billion INR | 110.78% |
| 2021 FY | 1.99 Billion INR | 388.96% |
| 2020 FY | 407.02 Million INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 39.632% |
| Hester Biosciences Limited | 2.29 Billion INR | -1.878% |
| Aarti Drugs Limited | 5.54 Billion INR | 57.938% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 10.649% |
| Albert David Limited | -278.36 Million INR | 938.369% |
| Alembic Limited | 66.9 Million INR | -3388.43% |
| Alkem Laboratories Limited | -1.6 Billion INR | 245.008% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | -914.974% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 29.258% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 12751.849% |
| Brooks Laboratories Limited | 49.48 Million INR | -4616.096% |
| Eris Lifesciences Limited | 13.8 Billion INR | 83.097% |
| FDC Limited | -57.75 Million INR | 4141.003% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 182.098% |
| Gufic Biosciences Limited | 3.19 Billion INR | 26.94% |
| Hikal Limited | 7.96 Billion INR | 70.707% |
| Ind-Swift Limited | 9.5 Billion INR | 75.456% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 311.91% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 267.905% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 91.379% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | 1928.421% |
| Lupin Limited | 19.38 Billion INR | 87.961% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -139.161% |
| Medico Remedies Limited | 78.67 Million INR | -2866.254% |
| Morepen Laboratories Limited | -231.17 Million INR | 1109.525% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 62.098% |
| Orchid Pharma Limited | -1.31 Billion INR | 277.628% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 199.394% |
| RPG Life Sciences Limited | -364.7 Million INR | 739.912% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -1844.168% |
| Sigachi Industries Limited | 859.94 Million INR | -171.384% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | 76.736% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -1509.756% |
| Themis Medicare Limited | 764.96 Million INR | -205.082% |
| Unichem Laboratories Limited | 931.91 Million INR | -150.426% |
| Vaishali Pharma Limited | 119.13 Million INR | -1858.921% |
| Wanbury Limited | 1.1 Billion INR | -111.033% |
| Windlas Biotech Limited | -273.04 Million INR | 954.732% |
| ZIM Laboratories Limited | 983.6 Million INR | -137.266% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 156.194% |
| Ipca Laboratories Limited | 11.41 Billion INR | 79.556% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 103.22% |
| Venus Remedies Limited | -267.7 Million INR | 971.782% |
| Sakar Healthcare Limited | 790.93 Million INR | -195.063% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 36.811% |
| Divi's Laboratories Limited | -39.77 Billion INR | 105.868% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 146.559% |
| Mankind Pharma Limited | -1.74 Billion INR | 233.483% |
| Sequent Scientific Limited | 4.17 Billion INR | 44.15% |
| Laurus Labs Limited | 24.35 Billion INR | 90.419% |
| Neuland Laboratories Limited | -214.05 Million INR | 1190.247% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 17.278% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 154.46% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 40.344% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 1038.037% |
| Wockhardt Limited | 18.27 Billion INR | 87.226% |
| Bal Pharma Limited | 1.26 Billion INR | -84.697% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 81.927% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 301.577% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 736.702% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 142.373% |
| Shilpa Medicare Limited | 9.06 Billion INR | 74.268% |
| Valiant Laboratories Limited | 649.9 Million INR | -259.094% |
| Ajanta Pharma Limited | -954.9 Million INR | 344.398% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | -684.248% |
| Granules India Limited | 9.28 Billion INR | 74.87% |
| Medicamen Biotech Limited | 160.31 Million INR | -1355.725% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -4950.226% |
| Piramal Enterprises Limited | 491.39 Billion INR | 99.525% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 92.668% |
| NATCO Pharma Limited | -5.81 Billion INR | 140.12% |
| Suven Life Sciences Limited | -1.63 Billion INR | 242.939% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -20.737% |
| Strides Pharma Science Limited | 23.25 Billion INR | 89.965% |
| Indoco Remedies Limited | 6.47 Billion INR | 63.965% |
| Alpa Laboratories Limited | 35.36 Million INR | -6499.44% |
| Lasa Supergenerics Limited | 205.79 Million INR | -1034.0% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 347.798% |